Key result
Ranolazine is reviewed as a treatment for chronic stable angina to update pharmacists on recent developments in cardiovascular pharmacotherapy.
This article reviews the role of ranolazine in managing chronic stable angina and highlights the importance of pharmacists staying current with cardiovascular pharmacotherapy.
Aids pharmacist updates on ranolazine for stable angina; leaves open its evolving role in guidelines.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Patricia Howard (2006) conducted a review in Chronic Stable Angina. Ranolazine was evaluated. Ranolazine is reviewed as a treatment for chronic stable angina to update pharmacists on recent developments in cardiovascular pharmacotherapy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: